SCHEMBL8489126

SCHEMBL8489126

O=C(Nc1ccc2ccccc2n1)N1CCCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.59
RAB9A P51151 9/20 0.59
SMN1; SMN2 Q16637 2/20 0.58
KDM4E B2RXH2 1/20 0.58
TP53 P04637 1/20 0.58
HSD17B10 Q99714 1/20 0.58
NPY5R Q15761 1/20 0.54
KMT2A Q03164 2/20 0.52
FAAH O00519 3/20 0.51
CNR2 P34972 1/20 0.50
HCAR2 Q8TDS4 1/20 0.48
MAPK1 P28482 2/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
ADORA2A P29274 1/20 0.48
ADORA2B P29275 1/20 0.48
ADORA1 P30542 1/20 0.48
NFKB1 P19838 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585730 0.86 POLB (0.55) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL11566043 0.76 GRM5 (0.60) NPC1RAB9ASMN1; SMN2KDM4EKMT2A
SCHEMBL3639088 0.76 FAAH (0.60) NPC1RAB9ASMN1; SMN2NPY5RKMT2A
SCHEMBL27657075 0.76 KMT2A (0.83) NPC1RAB9ASMN1; SMN2KMT2AMAPK1
SCHEMBL28409561 0.75 NPC1 (1.00) NPC1RAB9ASMN1; SMN2KDM4EKMT2A
SCHEMBL4927932 0.74 HDAC1 (0.66) NPC1RAB9ASMN1; SMN2NPY5RFAAH
SCHEMBL3764185 0.74 FAAH (0.71) FAAH
SCHEMBL28056008 0.74 NPC1 (0.72) NPC1RAB9ASMN1; SMN2TP53KMT2A
SCHEMBL4079342 0.74 TSHR (0.69) NPC1RAB9ASMN1; SMN2KDM4EKMT2A
SCHEMBL16585513 0.74 TRPV1 (0.59) NPC1RAB9ASMN1; SMN2KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999021835-A1 QUINOLINE DERIVATIVES AS H+-ATPase INHIBITORS AND AS BONE RESORPTION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-05-06 WO disclosed